Skip to main content
. 2017 Jun 20;158(9):2722–2740. doi: 10.1210/en.2017-00355

Table 4.

Cortical Geometry: Anabolic Therapies

Group Cortical Thickness Marrow Area Total Area Endocortical Perimeter Periosteal Perimeter
VEH: WT/Nmp4/ 0.190 ± 0.016/0.184 ± 0.007 0.964 ± 0.096/0.958 ± 0.026 1.841 ± 0.109/1.834 ± 0.092 3.843 ± 0.185/3.861 ± 0.121 5.243 ± 0.167/5.242 ± 0.175
PTH: WT/Nmp4/ 0.201 ± 0.009/0.196 ± 0.009 1.029 ± 0.090/0.992 ± 0.069 2.028 ± 0.118/2.024 ± 0.096 2.028 ± 0.118/3.955 ± 0.088 5.508 ± 0.172/5.476 ± 0.130
PTH+ALN: WT/Nmp4/ 0.200 ± 0.014/0.197 ± 0.007 1.046 ± 0.082/0.907 ± 0.129 2.074 ± 0.078/2.015 ± 0.145 4.104 ± 0.214/4.023 ± 0.302 5.633 ± 0.076/5.497 ± 0.235
PTH+ZOL: WT/Nmp4/ 0.207 ± 0.009/0.198 ± 0.011 1.012 ± 0.084/0.957 ± 0.092 2.074 ± 0.159/2.061 ± 0.126 4.038 ± 0.151/4.301 ± 0.477 5.595 ± 0.246/5.543 ± 0.220
PTH+RAL: WT/Nmp4/ 0.206 ± 0.015/0.203 ± 0.020 0.891 ± 0.136/0.822 ± 0.149 2.061 ± 0.116/2.005 ± 0.111 3.958 ± 0.404/3.860 ± 0.262 5.550 ± 0.225/5.546 ± 0.327
Anabolic therapy G: P = 0.0501 G: P = 0.0028 G: P = 0.23 G: P = 0.9952 G: P = 0.28
T: P = 0.0003 T: P < 0.0001 T: P < 0.0001 T: P = 0.0029 T: P < 0.0001
PTH+RAL A PTH A PTH+ZOL A PTH+ZOL A PTH+ZOL A
PTH+ZOL A PTH+ZOL A PTH+ALN A PTH+ALN AB PTH+ALN A
PTH A PTH+ALN A PTH+RAL A PTH AB PTH+RAL A
PTH+ALN A VEH A PTH A PTH+RAL B PTH A
VEH B PTH+RAL B VEH B VEH B VEH B
GxT: P = 0.92 GxT: P = 0.92 GxT: P = 0.89 GxT: P = 0.18 GxT: P = 0.86

The micro-CT analyses of the femoral cortical geometry in mice treated with the anabolic therapies. The data were analyzed using two-way analyses of variance to compare the anabolic therapies and the anticatabolic monotherapies. Statistical significance was set at P ≤ 0.05, and levels not connected by the same letter are significantly different. The data represent mean ± standard deviation, n = 7 to 12 mice per group.

Abbreviations: G, genotype; T, treatment.